October Pharma S.A.E (EGX:OCPH)

October Pharma S.A.E Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,689	1,310	1,200	1,200	978	600
Market Cap Growth	280.02%	9.14%	-	22.68%	63.02%	51.52%
Enterprise Value	5,045	1,817	1,518	1,257	1,193	853
Last Close Price	390.74	109.14	97.50	97.50	77.49	46.11
PE Ratio	28.40	9.98	7.98	10.55	8.16	6.80
PS Ratio	3.21	1.07	1.19	1.65	1.49	1.10
PB Ratio	7.06	2.30	2.04	2.82	2.88	2.36
P/TBV Ratio	7.98	2.68	2.41	3.67	4.18	4.25
P/FCF Ratio	13.18	-	10.17	-	4.04	12.59
P/OCF Ratio	12.63	30.29	7.83	-	3.73	11.26
EV/Sales Ratio	3.45	1.48	1.50	1.73	1.82	1.57
EV/EBITDA Ratio	12.02	5.19	4.61	5.68	5.52	5.20
EV/EBIT Ratio	13.31	5.67	4.94	6.31	6.10	5.88
EV/FCF Ratio	14.19	-	12.87	-	4.92	17.90
Debt / Equity Ratio	0.64	0.97	0.55	0.76	0.22	0.98
Debt / EBITDA Ratio	1.01	1.57	0.98	1.46	0.34	1.52
Debt / FCF Ratio	1.20	-	2.75	-	0.31	5.21
Net Debt / Equity Ratio	0.54	0.88	0.47	0.74	0.17	0.97
Net Debt / EBITDA Ratio	0.85	1.43	0.85	1.43	0.27	1.50
Net Debt / FCF Ratio	1.00	-50.91	2.36	-1.71	0.24	5.17
Asset Turnover	1.02	0.96	0.97	0.97	1.13	0.95
Inventory Turnover	2.37	2.89	2.45	1.78	2.15	2.55
Quick Ratio	0.47	0.39	0.56	0.36	0.75	0.31
Current Ratio	1.75	1.44	1.82	1.54	2.17	1.38
Return on Equity (ROE)	28.29%	26.20%	35.89%	34.18%	40.38%	40.64%
Return on Assets (ROA)	16.60%	15.70%	18.38%	16.57%	21.09%	15.84%
Return on Invested Capital (ROIC)	30.13%	24.76%	28.40%	26.38%	31.71%	24.55%
Return on Capital Employed (ROCE)	47.60%	47.00%	45.10%	37.90%	48.80%	44.50%
Earnings Yield	3.52%	11.59%	15.18%	10.90%	12.25%	14.71%
FCF Yield	7.59%	-0.75%	9.83%	-15.42%	24.79%	7.94%
Dividend Yield	-	-	2.56%	-	-	3.25%
Payout Ratio	11.06%	36.54%	9.86%	34.16%	28.54%	16.83%
Total Shareholder Return	-	-	2.56%	-	-	3.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.